News

Filter

Current filters:

OncologyNovartis

1 to 9 of 198 results

EC approves new indication for Novartis’ Jakavi

EC approves new indication for Novartis’ Jakavi

17-03-2015

The European Commission has approved Swiss pharma giant Novartis’ Jakavi (ruxolitinib) for the treatment…

BiotechnologyEuropeIncyte CorpJakafiJakaviNovartisOncologyRegulation

Prime Therapeutics welcomes FDA's approval of first biosimilar in USA, but says more clarity is needed

Prime Therapeutics welcomes FDA's approval of first biosimilar in USA, but says more clarity is needed

09-03-2015

Prime Therapeutics, a non-profit US pharmacy benefit manager serving more than 26 million members, has…

AmgenBiosimilarsBiotechnologyNeupogenNovartisOncologyRegulationSandozUSAZarxio

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

06-03-2015

Sandoz, the generics unit of Swiss pharma giant Novartis, today received approval from the US Food and…

AmgenBiosimilarsBiotechnologyNeupogenNovartisOncologyRegulationSandozUSAZarxioZarzio

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

AbbVie to acquire Pharmacyclics, aiming to create leading hematological oncology franchise

05-03-2015

US drugmaker AbbVie revealed late yesterday that it has reached an agreement to acquire US biopharma…

AbbVieBiotechnologyHematologyImbruvicaJohnson & JohnsonMergers & AcquisitionsNovartisOncologyPharmacyclics

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

Three new drugs recommended for approval by EMA/CHMP

Three new drugs recommended for approval by EMA/CHMP

27-02-2015

Three new medicines have been recommended for approval at the February 2015 meeting of the European Medicines…

AmgenEuropeJinarcNephrology and HepatologyNovartisOncologyOtsuka PharmaceuticalPharmaceuticalRegulationRistempaVectibixZykadia

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

US FDA approves Novartis’ Farydak, the first HDAC inhibitor for MM patients

24-02-2015

The US Food and Drug Administration yesterday approved Swiss pharma giant Novartis’ Farydak (panobinostat,…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

1 to 9 of 198 results

Back to top